Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
4.200
-0.240 (-5.41%)
At close: Nov 20, 2024, 4:00 PM
4.400
+0.200 (4.76%)
Pre-market: Nov 21, 2024, 7:32 AM EST
Telomir Pharmaceuticals Employees
As of December 31, 2023, Telomir Pharmaceuticals had 9 total employees, including 1 full-time and 8 part-time employees.
Employees
9
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,551,284
Market Cap
124.36M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 185 |
| Seer, Inc. | 147 |
| Adverum Biotechnologies | 121 |
| Compugen | 68 |
| Candel Therapeutics | 42 |
| Cardiff Oncology | 32 |
| Skye Bioscience | 11 |
| Inhibikase Therapeutics | 9 |
TELO News
- 1 hour ago - Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 - Accesswire
- 7 weeks ago - Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday - Accesswire
- 2 months ago - Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - Accesswire
- 3 months ago - Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Accesswire
- 3 months ago - Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman - GlobeNewsWire
- 5 months ago - Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes - GlobeNewsWire
- 5 months ago - Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel - GlobeNewsWire
- 6 months ago - Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1 - GlobeNewsWire